530 2. Di Fiore F, Lecleire S, Merle V, et al. Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol. 2005;17:641–7. 3. Theocharis GJ, Thomopoulos KC, Sakellaropoulos G, et al. Changing trends in the epidemiology and clinical outcome of acute upper gastrointestinal bleeding in a defined geographical area in Greece. J Clin Gastroenterol. 2008;42:128–33. 4. Hearnshaw SA, Logan RF, Lowe D, et al.: Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut. 2010, 59:1022–1029. This nationwide UK audit provides important information on the epidemiology of upper gastrointestinal bleeding, the use of endoscopy and other interventions, and outcome with compar- isons with published standards. One of the striking findings was the underuse of early endoscopy in patients at high risk of rebleeding. In this group, only 74% received endoscopy during admission, and only 50% underwent endoscopy within the recommended 24 hrs. 5. Czernichow P, Hochain P, Nousbaum JB, et al. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol. 2000;12:175–81. 6. Paspatis GA, Matrella E, Kapsoritakis A, et al. An epidemiolog- ical study of acute upper gastrointestinal bleeding in Crete, Greece. Eur J Gastroenterol Hepatol. 2000;12:1215–20. 7. Jairath V, Hearnshaw S, Brunskill SJ, et al.: Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev. 2010:CD006613. 8. Hearnshaw SA, Logan RF, Palmer KR, et al. Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2010;32:215–24. 9. Lau JY, Leung WK, Wu JC, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med. 2007;356:1631–40. 10. Barkun AN, Bardou M, Kuipers EJ, et al.: International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010, 152:101–113. This paper published by an international consensus group is of outstanding importance because it provides widely endorsed consensus recommendations on the management of patients with non-variceal upper gastrointestinal bleeding. Similarly important is alike consensus of the Asia-Pacific Working Group which allows for the specific needs of resource-limited countries and ethnic differences in the Asia-Pacific region [29]. 11. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–21. 12. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318–21. 13. Pang SH, Ching JY, Lau JY, et al. Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endo- scopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc. 2010;71:1134–40. 14. Schacher GM, Lesbros-Pantoflickova D, Ortner MA, et al. Is early endoscopy in the emergency room beneficial in patients with bleeding peptic ulcer? A “fortuitously controlled” study. Endos- copy. 2005;37:324–8. 15. Targownik LE, Murthy S, Keyvani L, et al. The role of rapid endoscopy for high-risk patients with acute nonvariceal upper gastrointestinal bleeding. Can J Gastroenterol. 2007;21:425–9. 16. Cappell MS. Therapeutic endoscopy for acute upper gastroin- testinal bleeding. Nat Rev Gastroenterol Hepatol. 2010;7:214– 29. 17. Kahi CJ, Jensen DM, Sung JJ, et al. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology. 2005;129:855–62. Curr Gastroenterol Rep (2011) 13:525–531 18. Laine L: Systematic review of endoscopic therapy for ulcers with clots: Can a meta-analysis be misleading? Gastroenterology. 2005, 129:2127; author reply 2127–2128. 19. Laine L, McQuaid KR: Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of random- ized controlled trials. Clin Gastroenterol Hepatol. 2009, 7:33–47; quiz 31–32. This meta-analysis is the largest of five recent meta- analyses comparing endoscopic techniques for treatment of peptic ulcer bleeding (Table 1) and in addition also compares different pharmacotherapeutic regimens after endoscopic hemostatic ther- apy. Recommendations following these meta-analyses were valu- able for the development of international guidelines. 20. Chung SC, Leong HT, Chan AC, et al. Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial. Gastrointest Endosc. 1996;43:591–5. 21. Rutgeerts P, Rauws E, Wara P, et al. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet. 1997;350:692–6. 22. Kurokohchi K, Maeta T, Ohgi T, et al. Successful treatment of a giant exposed blood vessel in a gastric ulcer by endoscopic sclerotherapy with N-butyl-2-cyanoacrylate. Endoscopy. 2007;39 Suppl 1:E250. 23. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol. 2007;102:279–89. quiz 469. 24. Sung JJ, Tsoi KK, Lai LH, et al. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007;56:1364–73. 25. Barkun AN, Martel M, Toubouti Y, et al. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc. 2009;69:786–99. 26. Yuan Y, Wang C, Hunt RH. Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials. Gastrointest Endosc. 2008;68:339–51. 27. Lin HJ, Perng CL, Sun IC, et al. Endoscopic haemoclip versus heater probe thermocoagulation plus hypertonic saline- epinephrine injection for peptic ulcer bleeding. Dig Liver Dis. 2003;35:898–902. 28. Sung JJ, Luo D, Wu JC, et al.: Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy. 2011, 43:291–295. This prospective pilot study assessed the effective- ness and safety of a new hemospray for active ulcer bleeding. The high rate of immediate hemostasis and the low rebleeding rate, without major side effects make this a new very promising endoscopic therapy which needs further study in larger patient samples. 29. Sung JJ, Chan FK, Chen M, et al.: Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut. 2011. 30. Chiu PW, Joeng HK, Choi CL, et al. Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endo- scopic factors? Endoscopy. 2006;38:726–9. 31. Ripoll C, Banares R, Beceiro I, et al. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol. 2004;15:447–50. 32. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia–a post hoc analysis from the Cochrane Collaboration. Aliment Pharmacol Ther. 2005;21:1055–61. 33. Sung JJ, Barkun A, Kuipers EJ, et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2009;150:455–64.